TABLE 1.
Characteristics of analytic sample at baseline (488 Matched Pairs)
Variable | Response | Cases | Controls | P value |
---|---|---|---|---|
Race* | white | 290 | 290 | – |
African American | 198 | 198 | ||
Mean Age at cohort entry, y* | 65.3 ± 7.4 | 65.4 ± 7.4 | – | |
Date of 1st benign specimen* | ||||
Median | 5/4/1995 | 4/12/1995 | – | |
Range | 1/19/90–11/25/02 | 1/18/90–9/30/02 | ||
Years to case diagnosis or follow-up time for controls* | ||||
Median | 4.15 | 4.15 | – | |
Range | 1.01–15.09 | 1.01–15.09 | ||
Mean serum PSA at cohort entry, ng/mL | 7.82 ± 7.40 | 5.91 ± 5.49 | < 0.0001 | |
Mean PSA velocity, ng/mL/year | 7.97 ± 97.12 | −0.06 ± 2.49 | < 0.0001 | |
Mean number of PSA tests from cohort entry to diagnosis (cases) or reference (controls) date | 6.61 ± 3.56 | 5.55 ± 3.18 | < 0.0001 |
Abbreviation: PSA, prostate-specific antigen.
Paired Wilcoxon Sign Rank Test
Matching variable.